Cambridge, MA, United States of America

Arnav Chhabra

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arnav Chhabra: Innovator in Immunotolerant Engineered Human Tissue Constructs

Introduction

Arnav Chhabra is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of biomedical engineering. His work focuses on developing innovative solutions for immune tolerance, particularly through engineered human tissue constructs.

Latest Patents

Chhabra holds a patent for "Compositions and methods for immune tolerance." This patent describes immunotolerant engineered human tissue constructs that are suitable for implantation into subjects. The constructs are designed to provide controllable immunotolerance through an inducible system. Additionally, the patent outlines methods for making and using these immunotolerant engineered tissue constructs.

Career Highlights

Throughout his career, Arnav Chhabra has worked with prestigious institutions, including the Massachusetts Institute of Technology and The General Hospital Corporation. His experience in these organizations has allowed him to advance his research and contribute to significant innovations in the field.

Collaborations

Chhabra has collaborated with esteemed colleagues such as Sangeeta N. Bhatia and Marcela V. Maus, further enhancing the impact of his work in the biomedical community.

Conclusion

Arnav Chhabra's innovative work in immunotolerant engineered human tissue constructs showcases his dedication to advancing medical science. His contributions are paving the way for new treatments and therapies in the field of immunology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…